Dermata Therapeutics Inc (DRMA): may churn another week at best, but we w...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: Capitalvaluetrade post# 85

Monday, 05/22/2023 12:38:58 AM

Monday, May 22, 2023 12:38:58 AM

may churn another week at best, but we will see large volume spikes and large price spikes in weeks ahead-

Keep Last Read

Next 10 Prev Next

Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/07/2024 08:49:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:06:20 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:05:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 09:16:49 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/02/2024 09:15:41 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/15/2024 04:15:18 AM
Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:06:12 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:01:23 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:00:44 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:00:36 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/07/2023 09:05:59 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:09:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:08:14 PM

InvestorsHub NewsWire

Only $200 per official company press release!